Ebola outbreak becomes deadliest in DR Congo’s history - UN News
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
This article is an excerpt. To read the full content, visit the original source. UN News
Related articles
Congo-Kinshasa: Inside Bunia's Fight to Protect Families From DR Congo's Deadliest Ebola Outbreak - allAfrica.com
Efforts to contain Ebola are starting to pay off in Bunia, the capital of the Democratic Republic of Congo's Ituri province and epicentre of the deadliest outbreak of the disease in the country's history. More than 4,000 people have died in five months, but the response is beginning to show results, as teams work to rebuild confidence in health services, protect women and children and support survivors. The outbreak, the 17th in the Democratic Republic of Congo (DRC), has been classified by the World Health Organization as a public health emergency of international concern.
Inside the study for a remedy to fight Congo's deadliest Ebola outbreak - PBS
RWAMPARA, Congo (AP) — More than 250 participants have been enrolled in a trial for a drug that could stop them from contracting Ebola in Congo, in what experts have described as a critical step to try to fight the deadliest outbreak of the disease in the Central African country. The drug is targeted at Bundibugyo virus, which is responsible for the fast-moving outbreak and is without an approved vaccine or treatment. The trial began in July and is one of several studies launched to find some protection and another way of at least slowing the outbreak.
European Medical Journal | HIV linked to early signs of heart dysfunction - European AIDS Treatment Group
Patient-centered financial navigation assistance helps reduce financial toxicity among cancer patients - Medical Xpress
Among cancer patients, the high financial cost of cancer care is a prevalent problem. This financial burden is also associated with potentially harmful behavioral strategies that patients might use to cope with costs, such as delaying or forgoing treatment and skipping medications. Collectively, researchers refer to this impact as financial toxicity.
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
0 comments
No comments yet. Be the first to share your thoughts!